Latency and Reactivation of a Glycoprotein E Negative Bovine Herpesvirus Type 1 Vaccine: Influence of Virus Load and Effect of Specific Maternal Antibodies
[en] The effects of the vaccination of neonatal calves with a glycoprotein E (gE)-negative bovine herpesvirus type 1 (BHV-1) were investigated in naive and passively immunised calves either with the recommended dose or a 5-fold concentrated one. After inoculation (PI), all calves excreted the virus vaccine except three passively immunised calves inoculated with the lower titre. No antibody response could be detected in passively immunised calves, whatever the dose used, and they all became BHV-1 seronegative and remained so after dexamethasone treatment (PDT). Nevertheless, as shown by a gamma-interferon assay, all calves that excreted the vaccine PI developed a cell-mediated immune response and a booster response was observed PDT, suggesting viral reactivation. The vaccine virus was recovered PDT from nasal secretions in two calves and BHV-1 DNA were detected in trigeminal ganglia from five calves belonging to all inoculated groups. The results show that the BHV-1 gE-negative vaccine can establish latency not only in naive but also in passively immunised neonatal calves after a single intranasal inoculation. Moreover, this study shows for the first time that the gE-negative vaccine, when used in passively immunised calves, can lead to seronegative vaccine virus carriers.
Disciplines :
Microbiology Veterinary medicine & animal health
Author, co-author :
Lemaire, Mylène
Schynts, Frédéric
Meyer, Gilles
Georgin, Jean-Pierre
Baranowski, Eric
Gabriel, Annick ; Université de Liège - ULiège > Département de morphologie et pathologie > Anatomie des animaux domestiques
Ros, Carol
Belak, Sandor
Thiry, Etienne ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Virologie, épidémiologie et pathologie des maladies virales
Language :
English
Title :
Latency and Reactivation of a Glycoprotein E Negative Bovine Herpesvirus Type 1 Vaccine: Influence of Virus Load and Effect of Specific Maternal Antibodies
Pastoret P.-P., Thiry E., Brochier B., Derboven G., Vindevogel H. (1984) The role of latency in the epizootiology of infectious bovine rhinotracheitis., Wittmann G, Gaskell RM, Rziha H-J, editors. Latent herpesvirus infections in veterinary medicine. Boston: Nijhoff; 221-227.
Wyler R., Engels M., Schwyzer M. (1989) Infectious bovine rhinotracheitis/vulvovaginitis (BHV1)., Wittmann G, editor. Herpesvirus diseases of cattle, horses and pigs. Boston: Kluwer Academic; 1-72.
Tikoo S.K., Campos M., Babiuk L.A. (1995) Bovine herpesvirus 1 (BHV-1): Biology, pathogenesis, and control. Adv Virus Res 45:191-223.
Strube W., Auer S., Block W. (1996) A gE deleted infectious bovine rhinotracheitis marker vaccine for use in improved bovine herpesvirus 1 control programs. Vet Microbiol 53:181-189.
De Wit J.J., Hage J.J., Brinkhof J., Westenbrink F. (1998) A comparative study of serological tests for use in the bovine herpesvirus 1 eradication programme in The Netherlands. Vet Microbiol 61:153-163.
Kaashoek M.J., Moerman A., Madic J. (1994) A conventionally attenuated glycoprotein E-negative strain of bovine herpesvirus type 1 is an efficacious and safe vaccine. Vaccine 12:439-444.
Kaashoek M.J., Moerman A., Madic J. (1995) An inactivated vaccine based on a glycoprotein E-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 13:342-346.
Van Oirschot J.T., Kaashoek M.J., Maris-Veldhuis M.A., Weerdmeester K., Rijsewijk F.A. (1997) An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J Virol Methods 67:23-34.
Davies D.H., Carmichael L.E. (1973) Role of cell-mediated immunity in the recovery of cattle from primary and recurrent infections with infectious bovine rhinotracheitis virus. Infect Immun 8:510-518.
Nettleton P.F., Sharp J.M., Herring A.J. (1984) Infectious bovine rhinotracheitis virus excretion after vaccination, challenge, and immunosuppression., Wittmann G, Gaskell RM, Rziha H-J, editors. Latent herpesvirus infections in veterinary medicine. Boston: Martinus Nijhoff; 191-209.
Thiry E., Brochier B., Lansival G. (1983) Etude sur l'excrétion et la réexcrétion spontanée de deux souches vaccinales du virus de la rhinotrachéite infectieuse bovine (Bovine herpesvirus 1) par des veaux sains maintenus en station de sélection. Ann Méd Vét 127:625-634.
Kit S., Qavi H., Gaines J.D., Billingsley P., McConnell S. (1985) Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves. Arch Virol 86:63-83.
Whetstone C.A., Miller J.M., Seal B.S., Bello L.J., Lawrence W.C. (1992) Latency and reactivation of a thymidine kinase-negative bovine herpesvirus 1 deletion mutant. Arch Virol 122:207-214.
Jacobs L. (1994) Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae. Arch Virol 137:209-228.
Meignier B., Longnecker R., Mavromara-Nazos P., Sears A.E., Roizman B. (1988) Virulence of and establishment of latency by genetically engineered deletion mutants of herpes simplex virus 1. Virology 162:251-254.
Bosch J.C., Kaashoek M.J., Van Oirschot J.T. (1997) Inactivated bovine herpesvirus 1 marker vaccines are more efficacious in reducing virus excretion after reactivation than a live marker vaccine. Vaccine 15:1512-1517.
Straub O.C. (1997) Experiences with two BHV-1 marker vaccines. The Bovine Practitioner 31:46-48.
Mars M.H., De Jong M.C., Van Oirschot J.T. (2000) A gE-negative bovine herpesvirus 1 vaccine strain is not re-excreted nor transmitted in an experimental cattle population after corticosteroid treatments. Vaccine 18:1975-1981.
Van Engelenburg F.A., Kaashoek M.J., Van Oirschot J.T., Rijsewijk F.A. (1995) A glycoprotein E deletion mutant of bovine herpesvirus 1 infects the same limited number of tissues in calves as wild-type virus, but for a shorter period. J Gen Virol 76:2387-2392.
Menanteau-Horta A.M., Ames T.R., Johnson D.W., Meiske J.C. (1985) Effect of maternal antibody upon vaccination with infectious bovine rhinotracheitis and bovine virus diarrhea vaccines. Can J Comp Med 49:10-14.
Lemaire M., Meyer G., Baranowski E. (2000) Production of bovine herpesvirus type 1 seronegative latent carriers by administration of a live-attenuated vaccine in passively immunized calves. J Clin Microbiol 38:4233-4238.
Lemaire M., Weynants V., Godfroid J. (2000) Effects of bovine herpesvirus type 1 infection in calves with maternal antibodies on immune response and virus latency. J Clin Microbiol 38:1885-1894.
Lemaire M., Hanon E., Schynts F., Meyer G., Thiry E. (2000) Specific passive immunity reduces the excretion of glycoprotein E-negative bovine herpesvirus type 1 vaccine strain in calves. Vaccine 19:1013-1017.
Lemaire M., Schynts F., Meyer G., Thiry E. (1999) Antibody response to glycoprotein E after bovine herpesvirus type 1 infection in passively immunised, glycoprotein E-negative calves. Vet Rec 144:172-176.
Schynts F., Baranowski E., Lemaire M., Thiry E. (1999) A specific PCR to differentiate between gE negative vaccine and wildtype bovine herpesvirus type 1 strains. Vet Microbiol 66:187-195.
Ros C., Belak S. (1999) Studies of genetic relationships between bovine, caprine, cervine, and rangiferine alphaherpesviruses and improved molecular methods for virus detection and identification. J Clin Microbiol 37:1247-1253.
Kramps J.A., Magdalena J., Quak J. (1994) A simple, specific, and highly sensitive blocking enzyme-linked immunosorbent assay for detection of antibodies to bovine herpesvirus 1. J Clin Microbiol 32:2175-2181.
Godfroid J., Czaplicki G., Kerkhofs P. (1996) Assessment of the cell-mediated immunity in cattle infection after bovine herpesvirus 4 infection, using an in vitro antigen-specific interferon-gamma assay. Vet Microbiol 53:133-141.
Rijsewijk F.A., Verschuren S.B., Madic J., Ruuls R.C., Renaud P., Van Oirschot J.T. (1999) Spontaneous BHV1 recombinants in which the gI/gE/US9 region is replaced by a duplication/inversion of the US1.5/US2 region. Arch Virol 144:1527-1537.
Marshall R.L., Letchworth G.J. (1988) Passively administered neutralizing monoclonal antibodies do not protect calves against bovine herpesvirus 1 infection. Vaccine 6:343-348.
Bradshaw B.J., Edwards S. (1996) Antibody isotype responses to experimental infection with bovine herpesvirus 1 in calves with colostrally derived antibody. Vet Microbiol 53:143-151.
Lemaire M., Meyer G., Ernst E. (1995) Latent bovine herpesvirus 1 infection in calves protected by colostral immunity. Vet Rec 137:70-71.
Snowdon W.A. (1965) The IBR-IPV virus: Reaction to infection and intermittent recovery of virus from experimentally infected cattle. Aust Vet J 41:135-142.
Bitsch V. (1973) Infectious bovine rhinotracheitis virus infection in bulls, with special reference to preputial infection. Appl Microbiol 26:337-343.
Huck R.A., Millar P.G., Woods D.G. (1973) Experimental infection of maiden heifers by the vagina with infectious bovine rhinotracheitis-infectious pustular vulvo-vaginitis virus. An epidemiological study. J Comp Pathol 83:271-279.
Thiry E., Brochier B., Hanton G., Derboven G., Pastoret P.-P. (1983) Réactivation du virus de la rhinotrachéite infectieuse bovine (Bovine herpesvirus 1, BHV-1) non accompagnée de réexcrétion de particules infectieuses, après injection de dexaméthasone, chez des bovins préalablement soumis au test d'hypersensibilité retardée au BHV-1. Ann Méd Vét 127:377-381.
Mengeling W.L. (1991) Anamnestic immune response of pigs to pseudorabies virus: Latent virus reactivation versus direct oronasal and parenteral exposure to virus. J Vet Diagn Invest 3:133-136.
Fuchs M., Hubert P., Detterer J., Rziha H.-J. (1999) Detection of bovine herpesvirus type 1 in blood from naturally infected cattle by using a sensitive PCR that discriminates between wild-type virus and virus lacking glycoprotein E. J Clin Microbiol 37:2498-2507.
Straub O.C. (1987) Untersuchungen zur bestimmung der rinderinfektiösen dosis bei einem virulenten und einem avirulenten BHV1-stamm zur ermittlung der viruslatenz. Tieraerztl Umschau 42:231-234.
Mars M.H., De Jong M.C., Van Oirschot J.T. (2000) A gE-negative BHV1 vaccine virus strain cannot perpetuate in cattle populations. Vaccine 18:2120-2124.
Jacobs L., Mulder W.A., Van Oirschot J.T., Gielkens A.L., Kimman T.G. (1993) Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity. J Gen Virol 74:2201-2206.
Hage J.J., Schukken Y.H., Barkema H.W., Benedictus G., Rijsewijk F.A., Wentink G.H. (1996) Population dynamics of bovine herpesvirus 1 infection in a dairy herd. Vet Microbiol 53:169-180.
